Hospital
Salem Community Hospital
Salem Community Hospital was paid $11.69M by Medicaid between Jan 2018 and Dec 2024, across 221 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.
33Billing provider infoSALEM COMMUNITY HOSPITAL
SALEM, OH 44460
SALEM, OH 44460
33aNPI1639131535assigned 04/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.69M
24GClaims341,312
24DCodes billed221
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#70 of 101
Median peer was paid$22.32M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,618 | $916K | |
| 2019 | 34,803 | $970K | |
| 2020 | 29,802 | $1.11M | |
| 2021 | 35,744 | $1.33M | |
| 2022 | 39,220 | $1.52M | |
| 2023 | 96,360 | $3.41M | |
| 2024incomplete | 72,765 | $2.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 19,218 | 17,034 | $2.40M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 15,622 | 14,615 | $1.82M |
| 96361 | Intravenous infusion, hydration; each additional hour | 15% | 5,762 | 4,526 | $1.75M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.1% | 9,272 | 8,191 | $594K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 3,656 | 3,405 | $379K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.1% | 2,892 | 1,973 | $360K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.9% | 1,141 | 955 | $334K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 1,304 | 1,102 | $282K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.1% | 2,252 | 1,096 | $246K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.9% | 3,063 | 2,816 | $222K |
| 80053 | Comprehensive metabolic panel | 1.8% | 26,350 | 21,330 | $212K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 1,655 | 1,420 | $196K |
209 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 838 | $195K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.6% | 1,169 | $185K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 831 | $173K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.4% | 455 | $164K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.4% | 2,291 | $159K |
| 95886 | 1.4% | 706 | $159K | |
| 87081 | <1% | 4,830 | $115K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 276 | $86K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 899 | $77K |
| 96367 | <1% | 740 | $75K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,159 | $58K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 31,763 | $58K |
| 74018 | <1% | 1,006 | $54K | |
| 76830 | Ultrasound, transvaginal | <1% | 395 | $52K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,584 | $52K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 190 | $47K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 478 | $46K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 205 | $46K |
| G0378 | Hospital observation service, per hour | <1% | 548 | $40K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 61 | $38K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,100 | $38K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 216 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,047 | $37K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 821 | $35K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,783 | $34K |
| 80061 | Lipid panel | <1% | 2,503 | $31K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 325 | $29K |
| H2020 | Therapeutic behavioral services, per diem | <1% | 245 | $28K |
| 82607 | <1% | 1,869 | $25K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 39,078 | $25K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 85 | $23K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,362 | $23K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,965 | $23K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 982 | $22K |
| 82728 | <1% | 2,586 | $22K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 125 | $21K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 622 | $19K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 20 | $19K |
| 97597 | <1% | 331 | $19K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,037 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,512 | $17K |
| 81003 | <1% | 13,120 | $17K | |
| 84439 | <1% | 676 | $15K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,994 | $15K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 58 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 865 | $14K |
| 83540 | <1% | 2,576 | $13K | |
| 97116 | <1% | 709 | $13K | |
| 97161 | <1% | 265 | $12K | |
| 71250 | <1% | 130 | $11K | |
| 84484 | <1% | 4,649 | $11K | |
| 97162 | <1% | 118 | $11K | |
| 97165 | <1% | 171 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,497 | $9K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 49 | $9K |
| 86140 | <1% | 649 | $9K | |
| 73630 | <1% | 444 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,018 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 822 | $9K |
| 36591 | <1% | 2,149 | $8K | |
| 85027 | <1% | 994 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 313 | $8K |
| 84466 | <1% | 2,040 | $8K | |
| 86038 | <1% | 332 | $8K | |
| 76641 | <1% | 48 | $8K | |
| 84153 | <1% | 478 | $8K | |
| 74178 | <1% | 43 | $7K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 14 | $7K |
| 71271 | <1% | 44 | $7K | |
| 73030 | <1% | 365 | $7K | |
| 84145 | <1% | 1,246 | $7K | |
| 83735 | <1% | 3,318 | $7K | |
| 73130 | <1% | 310 | $6K | |
| 73610 | <1% | 429 | $6K | |
| 73564 | <1% | 312 | $6K | |
| 93971 | <1% | 66 | $6K | |
| 59025 | Fetal non-stress test | <1% | 92 | $6K |
| 82746 | <1% | 834 | $5K | |
| Q3014 | Telehealth originating site facility fee | <1% | 378 | $5K |
| 83550 | <1% | 484 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 222 | $4K |
| 73110 | <1% | 278 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,204 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 209 | $3K |
| 83615 | <1% | 1,823 | $3K | |
| 83605 | <1% | 1,066 | $3K | |
| 82570 | <1% | 349 | $3K | |
| 72110 | <1% | 95 | $3K | |
| 85610 | <1% | 1,252 | $3K | |
| 87186 | <1% | 739 | $3K | |
| 85651 | <1% | 628 | $3K | |
| 84703 | <1% | 4,133 | $3K | |
| 82140 | <1% | 335 | $3K | |
| 82784 | <1% | 409 | $3K | |
| 80076 | <1% | 201 | $3K | |
| 87088 | <1% | 628 | $3K | |
| 76391 | <1% | 15 | $3K | |
| 86850 | <1% | 192 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,499 | $3K |
| 73502 | <1% | 176 | $3K | |
| 82962 | <1% | 1,666 | $3K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 3,862 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $2K |
| 95819 | <1% | 18 | $2K | |
| 72100 | <1% | 59 | $2K | |
| 82378 | <1% | 614 | $2K | |
| 83880 | <1% | 748 | $2K | |
| 86900 | <1% | 277 | $2K | |
| 88142 | <1% | 154 | $2K | |
| 87510 | <1% | 89 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 23 | $2K |
| 82043 | <1% | 325 | $2K | |
| 95912 | <1% | 246 | $2K | |
| H2012 | Behavioral health day treatment, per hour | <1% | 50 | $2K |
| 84550 | <1% | 298 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 514 | $2K |
| 96417 | <1% | 63 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 27 | $2K |
| 83690 | <1% | 1,758 | $2K | |
| 87480 | <1% | 89 | $2K | |
| 76536 | <1% | 14 | $1K | |
| 87040 | <1% | 582 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 15 | $1K |
| 82077 | <1% | 516 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $1K |
| 82565 | <1% | 210 | $1K | |
| 82553 | <1% | 411 | $1K | |
| 96376 | <1% | 668 | $1K | |
| 87660 | <1% | 89 | $1K | |
| 94060 | <1% | 13 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 59 | $1K |
| 85379 | <1% | 590 | $990.03 | |
| 87070 | <1% | 163 | $901.20 | |
| 82248 | <1% | 81 | $806.65 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 646 | $786.25 |
| 85730 | <1% | 555 | $747.65 | |
| 86901 | <1% | 277 | $724.52 | |
| 84100 | <1% | 174 | $693.42 | |
| 82550 | <1% | 509 | $585.39 | |
| 86706 | <1% | 28 | $557.98 | |
| 94727 | <1% | 12 | $522.42 | |
| 87205 | <1% | 160 | $466.48 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,874 | $459.34 |
| 83921 | <1% | 132 | $421.28 | |
| 86431 | <1% | 27 | $410.50 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,622 | $409.47 |
| 80143 | <1% | 155 | $407.01 | |
| 00731 | <1% | 124 | $356.64 | |
| 73080 | <1% | 18 | $333.93 | |
| 86592 | <1% | 30 | $321.54 | |
| 86364 | <1% | 17 | $305.73 | |
| 84436 | <1% | 41 | $287.80 | |
| 84403 | <1% | 24 | $281.66 | |
| 86003 | <1% | 21 | $272.47 | |
| 94729 | <1% | 12 | $261.18 | |
| 87077 | <1% | 22 | $254.52 | |
| 86231 | <1% | 15 | $254.22 | |
| 82525 | <1% | 13 | $234.98 | |
| 82785 | <1% | 15 | $219.61 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 17 | $210.08 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,069 | $207.11 |
| 82105 | <1% | 14 | $198.59 | |
| 85014 | <1% | 40 | $197.11 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 217 | $188.79 |
| 88312 | <1% | 367 | $186.41 | |
| 80074 | <1% | 14 | $177.39 | |
| 80179 | <1% | 134 | $177.10 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,973 | $157.47 |
| 82803 | <1% | 331 | $153.39 | |
| 85045 | <1% | 153 | $152.93 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 30 | $125.00 |
| 90473 | <1% | 48 | $116.67 | |
| 85018 | <1% | 42 | $115.63 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,023 | $92.28 |
| 84702 | <1% | 15 | $89.44 | |
| 88313 | <1% | 488 | $89.23 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 301 | $88.10 |
| 84479 | <1% | 27 | $80.04 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 119 | $79.59 |
| 84156 | <1% | 20 | $74.65 | |
| 84165 | <1% | 33 | $70.89 | |
| 84155 | <1% | 35 | $64.39 | |
| A9270 | Non-covered item or service | <1% | 2,862 | $62.95 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 557 | $57.45 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,948 | $56.67 |
| 84520 | <1% | 14 | $37.32 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 333 | $31.67 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,173 | $31.30 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 186 | $28.81 |
| 86334 | <1% | 14 | $28.40 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,173 | $19.38 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 446 | $16.50 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 398 | $12.97 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 175 | $12.09 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 31 | $10.49 |
| 87075 | <1% | 27 | $10.09 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 948 | $5.11 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 289 | $4.32 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 60 | $3.27 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 95 | $2.52 |
| 00811 | 0% | 103 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 21 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 15 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 13 | $0.00 |
| 00813 | 0% | 174 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 45 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 39 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 31 | $0.00 |
| 00126 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHACKSTEDDE, ANITA (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Salem Community Hospital | Salem, OH | $1.04M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.